Literature DB >> 16112091

Vulnerability of synaptic plasticity in the complexin II knockout mouse to maternal deprivation stress.

Yoshitake Yamauchi1, Li-Hong Qin, Makoto Nishihara, Ken Sawada, Kunio Kato, Shimpei Inoue.   

Abstract

The alterations in brain function and structure seen in schizophrenia are mediated by genetics as well as vulnerability due to environmental factors. Postmortem studies in schizophrenic patients have shown that expression of complexin II, which is involved in neurotransmitter release at central nervous system synapses, is decreased in the brain. We examined the physiological characteristics of complexin II gene-deficient mice subjected to maternal deprivation stress to determine whether psychological stress during the early stage of life affected the development of brain function. We compared the electrophysiological properties of CA1 hippocampal pyramidal neurons and spatial memory in the Morris water maze test in the wild-type mouse and the homozygous mutant. In the non-stressed mouse, no significant differences in transsynaptic responses and synaptic plasticity or spatial memory were seen, suggesting that complexin II does not play a critical role in transmitter release or synaptic plasticity under these conditions. In contrast, under conditions of maternal deprivation stress, the knockout mouse showed a significant decrease in post-tetanic potentiation and LTP induction and a significant impairment in Morris water Maze test compared to the wild-type mouse, suggesting that complexin II plays a significant role in neurotransmitter release and synaptic plasticity under this pathological condition. Taken together, these results show that mice lacking complexin II are vulnerable to maternal deprivation stress, which raises the possibility that the complexin II gene may be a factor in the onset of schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16112091     DOI: 10.1016/j.brainres.2005.07.015

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  4 in total

Review 1.  The evolution of drug development in schizophrenia: past issues and future opportunities.

Authors:  William T Carpenter; James I Koenig
Journal:  Neuropsychopharmacology       Date:  2007-11-28       Impact factor: 7.853

2.  The impact of maternal separation and isolation stress during stress hyporesponsive period on fear retention and extinction recall memory from 5-week- to 1-year-old rats.

Authors:  Pradeep Kumar Mishra; Bindu M Kutty; T R Laxmi
Journal:  Exp Brain Res       Date:  2018-10-29       Impact factor: 1.972

3.  Complexin2 modulates working memory-related neural activity in patients with schizophrenia.

Authors:  Johanna Hass; Esther Walton; Holger Kirsten; Jessica Turner; Rick Wolthusen; Veit Roessner; Scott R Sponheim; Daphne Holt; Randy Gollub; Vince D Calhoun; Stefan Ehrlich
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-10-09       Impact factor: 5.270

4.  Convergent functional genomics of schizophrenia: from comprehensive understanding to genetic risk prediction.

Authors:  M Ayalew; H Le-Niculescu; D F Levey; N Jain; B Changala; S D Patel; E Winiger; A Breier; A Shekhar; R Amdur; D Koller; J I Nurnberger; A Corvin; M Geyer; M T Tsuang; D Salomon; N J Schork; A H Fanous; M C O'Donovan; A B Niculescu
Journal:  Mol Psychiatry       Date:  2012-05-15       Impact factor: 15.992

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.